Literature DB >> 1764207

Cerebellar interpositus nucleus lesions disrupt classical nictitating membrane conditioning but not discriminative avoidance learning in rabbits.

J E Steinmetz1, L L Sears, M Gabriel, Y Kubota, A Poremba, E Kang.   

Abstract

Cerebellar interpositus nucleus lesions were given to 14 rabbits trained in two behavioral paradigms; discriminative avoidance conditioning of locomotor behavior and classical nictitating membrane conditioning. Bilateral lesions that prevented acquisition of the classically conditioned response on both the left and right side failed to affect the acquisition or performance of the conditioned discriminative avoidance response. The results are discussed in terms of differences in neural substrates that apparently subserve the two forms of learning.

Entities:  

Mesh:

Year:  1991        PMID: 1764207     DOI: 10.1016/s0166-4328(05)80182-2

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

1.  Medial geniculate lesions block amygdalar and cingulothalamic learning-related neuronal activity.

Authors:  A Poremba; M Gabriel
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

2.  Ethanol-exposed neonatal rats are impaired as adults in classical eyeblink conditioning at multiple unconditioned stimulus intensities.

Authors:  Derick H Lindquist; Greta Sokoloff; Joseph E Steinmetz
Journal:  Brain Res       Date:  2007-03-06       Impact factor: 3.252

3.  A magnetic resonance imaging-safe method for the study of human eyeblink conditioning.

Authors:  Jerillyn S Kent; D Michael Bailey; Jennifer M Vollmer; Sharlene D Newman; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick
Journal:  J Neurosci Methods       Date:  2013-03-13       Impact factor: 2.390

4.  Cerebellum volume and eyeblink conditioning in schizophrenia.

Authors:  Chad R Edwards; Sharlene Newman; Andrew Bismark; Patrick D Skosnik; Brian F O'Donnell; Anantha Shekhar; Joseph E Steinmetz; William P Hetrick
Journal:  Psychiatry Res       Date:  2008-01-28       Impact factor: 3.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.